Products and Services

Research Reagents

Cell Culture Reagents

Antibodies

Drug Discovery & Development

Human iPS cell derived Cardiomyocyte

Human iPS cell derived Neural Cells

Diabetes Research Tools and Services

Diagnostic & Flow Cytometry Services

Flow Cytometry Services

Clinical Diagnostics for Transplantation

ReproNeuro DA kit

ReproNeuro DA kit

Human iPS cell derived Neural Progenitor Cells for Dopaminergic Neuron

Cat. No. RCESD010

Contents:

  • Human iPS cell derived Neural Progenitor Cells (1x10^6 cells/vial x 3)
  • Thawing medium (30 mL)
  • Maturation medium (40 mL)
  • Additive A
  • Coating solution

Storage: Cells, -80 deg C and Others, -20 deg C

Shipping: Dry ice
 
Human dompaminergic neurons are obtained by differentiating from human iPS cell derived neural progenitor cells using maturation medium and additive A attached.
The human dopaminergic neurons can be used effectively for research and drug discovery of CNS diseases including Parkinson's disease.

  • Human dopaminergic neuron
  • Expressing both bIII-tubulin (a neuron marker) and TH (a dopaminergic neuron marker) 
  • Dopamine release and uptake are observed
  • All lots are inspected by the functional assays


Additional ImageAdditional ImageAdditional Image

Immunostaining images of the NPCs cultured for 14 days

Dopaminergic neurons expressing both bIII-tubulin (a neuron marker) and TH (a dopaminergic neuron marker) are obtained after a 14-day culture.



Anti-bIII-tubulin (1:750), Sigma











Anti-tyrosine hydroxylase (TH) (1:250), Epitomics










Dopamine release in the medium: dopaminergic neurons derived from human iPS cells before/after KCl treatment.

The dopamine concentration in the culture medium increased on depolarization with 56 mM KCl. This result suggests that dopaminergic neurons derived from hiPSCs possess the ability of dopamine release.